Strahlentherapie und Onkologie

Papers
(The median citation count of Strahlentherapie und Onkologie is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Treatment of COVID-19 pneumonia with low-dose radiotherapy plus standard of care versus standard of care alone in frail patients49
Assoziation von alterstypischen strukturellen Veränderungen des Gehirns und Ganzhirnbestrahlung42
Neoadjuvante Therapie des lokal fortgeschrittenen Plattenepithelkarzinoms des Ösophagus41
Reply to Letter to the Editor: Reply to comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy40
Longer time to testosterone recovery impacts favorably on outcomes for prostate cancer following androgen deprivation and radiotherapy35
Neoadjuvante Chemoimmuntherapie gefolgt von einer dosis- und volumenreduzierten Chemoradiotherapie bei lokal fortgeschrittenen Kopf-Hals-Karzinomen33
Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients27
Impact of reduced interval from simulation CT to treatment delivery on dosimetric and positioning accuracy for total marrow lymph-node irradiation27
Application of delta radiomics based on cone-beam computed tomography in predicting radiotherapy efficacy for nasopharyngeal carcinoma26
Automated contouring for breast cancer radiotherapy in the isocentric lateral decubitus position: a neural network-based solution for enhanced precision and efficiency26
Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancer25
Stereoscopic X-ray image and thermo-optical surface guidance for breast cancer radiotherapy in deep inspiration breath-hold23
Significant aggravation of pre-existing myalgic encephalomyelitis/chronic fatigue syndrome following proton beam therapy for sphenoid wing meningioma: case report23
Abnormal visual and olfactory sensations during radiation therapy: a prospective study22
Dosimetric advantages for cardiac substructures in radiotherapy of esophageal cancer in deep-inspiration breath hold20
Assessing the quality of radiation oncology education in four German medical schools: a student perspective and comparison with DEGRO recommendations20
Langzeitergebnisse der ORATOR-Studie: Radiotherapie versus transorale roboter-assistierte Chirurgie in der Primärtherapie des Oropharynxkarzinoms19
Dosiseskalation bei der Radiotherapie inoperabler Ewing-Tumoren19
Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma19
Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer18
Correction to: Analysis and stress-test of the spatial accessibility to German radiation oncology centers18
Teaching communication skills in medical education17
Optimizing energy consumption in radiotherapy: standard vs. hypo-/ultra-hypofractionation and becoming SMART (specific, measurable, achievable in radiotherapy)17
Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours16
Intra-adaptational changes in online adaptive radiotherapy: from the ideal to the real dose16
Shaping the future of radiation oncology education: results of a nationwide student survey from Germany16
26th Annual SASRO Meeting16
Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center16
ACOUNEU – Radiochirurgie oder hypofraktionierte Strahlentherapie beim Vestibularis-Schwannom?15
Synthetic CTs for MRI-only brain RT treatment: integration of immobilization systems15
Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy15
Stereotaktische Radiotherapie plus Nivolumab bei NSCLC15
Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal c15
Cardiac metastasis in uterine cervical cancer15
Potential Single Nucleotide Polymorphisms markers for radiation dermatitis in head and neck cancer patients: a meta-analysis15
Can interventional radiotherapy (brachytherapy) be an alternative to surgery in early-stage oral cavity cancer? A systematic review14
Proton therapy in young breast cancer patients with germline TP53 and ATM mutations: a case series14
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)14
Comparison of integral doses to normal tissue and organs at risk between interstitial high-dose-rate brachytherapy and modern external-beam radiotherapy techniques in breast and head and neck cancer p14
Nintedanib zur Therapie der radiogenen Pneumonitis13
DEGRO 2023 Abstractbuch13
Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma12
Deutsche Gesellschaft für Radioonkologie (DEGRO) mahnt stationäre strahlentherapeutische Versorgung an12
Impact of dose volume parameters and clinical characteristics on radiation-induced acute oral mucositis for head and neck cancer patients treated with carbon-ion radiotherapy dose volume outcome analy12
Radio(chemo)therapy in anal cancer: evaluation of sex-specific disparities across AJCC stages12
Intensity modulated radiation therapy in prostate cancer—Better survival with higher total dose?12
Genomic analysis of radiosensitivity in breast cancer11
Thymic tumors: radiotherapy experience for single institute11
Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature11
Surface-guided DIBH radiotherapy for left breast cancer: impact of different thresholds on intrafractional motion monitoring and DIBH stability11
Determinants of radiation dose to immune cells during breast radiotherapy11
German radiation oncology’s next generation: a web-based survey of young biologists, medical physicists, and physicians—from problems to solutions11
Kein Vorteil einer Erhaltungstherapie mit Afatinib in der adjuvanten Therapie von Kopf-Hals-Tumoren10
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer10
Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature10
Stellenwert einer „targeted therapy“ beim EGFR-mutierten Lungenkarzinom nach erfolgter Radiochemotherapie10
Multidisciplinary treatment is necessary in glioblastoma with extracerebral metastases10
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis10
Die intraoperative Strahlentherapie (IORT) als mögliche Alternative zum vollständigen Verzicht auf eine adjuvante Radiotherapie nach brusterhaltender Operation bei älteren Patientinnen mit niedriger R10
Clinical and MRI factors influencing interobserver delineation variability of brain metastases before stereotactic radiotherapy10
Bridging gaps in care: medical student home visits and their influence on radiation oncology patients9
Neoadjuvantes FOLFIRINOX vs. neoadjuvante Radiochemotherapie und adjuvante Chemotherapie mit Gemcitabin für resektable und borderline-resektable Pankreaskarzinome (PREOPANC-2-Studie)9
The benefit of intravenous immune globulin in the treatment of delayed radiation myelopathy9
Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis9
Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer—final results of the prematurely terminated PORTAF trial9
Expert opinion9
Outcomes and PSA kinetics after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy (MRgSBRT) for prostate cancer9
Correction to: From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer9
Chemoradiotherapy for untreated Masaoka–Koga stage IVB thymic carcinoma: a single-center retrospective study8
Long-term survival in patients with brain metastases—clinical characterization of a rare scenario8
Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up8
Vergleich der radikalen Zystektomie mit der trimodalen Therapie beim muskelinvasiven Harnblasenkarzinom8
Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapy8
4DCT ventilation function image-based functional lung protection for esophageal cancer radiotherapy8
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities8
Organerhaltende Behandlung bei nodal-positiven Harnblasenkarzinomen8
Olaparib bei biochemischem Rezidiv des High-risk-Prostatakarzinoms nach Prostatektomie8
Neoadjuvant chemoradiotherapy in combination with deep regional hyperthermia followed by surgery for rectal cancer: a systematic review and meta-analysis8
Ampelopsis japonica enhances the effect of radiotherapy in non-small cell lung cancer8
Effect of simultaneous integrated boost concepts on photoneutron and distant out-of-field doses in VMAT for prostate cancer8
Radiotherapy for painful shoulder syndrome: a retrospective evaluation8
Keine abskopalen Effekte bei Kombination von Immuntherapie und stereotaktischer Radiotherapie bei Merkel-Zell-Karzinomen8
Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis8
Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays—results of the TARGIT BQR prospective phase IV trial8
Ultrahypofractionation of localized prostate cancer—an updated statement of the prostate cancer working group of the German Society of Radiation Oncology (DEGRO)8
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomy8
YB-1 activating cascades as potential targets in KRAS-mutated tumors8
Postoperative therapy patterns for thymic carcinoma with complete resection: retrospective analysis of 120 patients7
Outcomes of craniospinal radiotherapy in adult medulloblastoma: survival, long-term toxicities, and quality of life assessment with SF-12 and t-Cog7
CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study7
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy7
Clinical target volume radiomics from planning CT for pretreatment response prediction  in rectal cancer undergoing chemoradiotherapy7
Sekundärmalignome nach Ganzkörperbestrahlung pädiatrischer Leukämiepatienten – eine kritische Re-Evaluation der multizentrischen ALL-SCT-BFM-2003-Studie7
Correction to: Proton beam therapy versus trans-arterial chemoembolization for BCLC stage B hepatocellular carcinoma—a propensity-matched analysis7
Staphylococcus-aureus-Kolonisation als Risikofaktor der akuten Strahlenreaktion an der Haut7
Stereotaktische Radiotherapie bei funktionell inoperablem, aber technisch resektablem Pankreaskarzinom7
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway7
Pulmonary artery intimal sarcoma: Case report of a patient managed with multimodality treatment and a comprehensive literature review7
Pelvic insufficiency fractures in cervical cancer patients treated with definitive chemoradiation: impact of dosimetric and clinical factors7
Assessment and validation of glottic motion using cone-beam CT and real-time cine MRI7
Postoperative Radiotherapie für pT1–2-N0-Zungenkarzinome: Zeit für ein Umdenken?7
Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Associati7
Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis7
Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival7
Mepitel-Film zur Prävention der Radiodermatitis bei Brustbestrahlung7
The impact of sex on setup accuracy in radiotherapy for rectal cancer: a real-World observational study6
Ceftriaxone has a neuroprotective effect in a whole-brain irradiation-induced neurotoxicity model by increasing GLT-1 and reducing oxidative stress6
The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients6
Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients6
High radiation dose in chemoradiotherapy followed by immunotherapy with durvalumab in patients with stage III non-small cell lung cancer does not increase risk for pneumonitis6
DEGRO 2025 Abstractband6
Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer6
Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors6
Usability and usefulness of (electronic) patient identification systems—A cross-sectional evaluation in German-speaking radiation oncology departments6
Stereotaktische Radiotherapie beim primären Nierenzellkarzinom: neue Ergebnisse der FASTRACK-Studien6
Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis6
A new GPU-based Monte Carlo code for helium ion therapy6
Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma6
Correction to: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers6
Pentoxifylline and vitamin E for treating radiation-induced fibrosis in breast and head and neck cancer patients6
From case to care pathway: proactive detection and management of RCI-associated HLH in radiation oncology6
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients6
Breast cancer related lymphedema and shoulder mobility following radiotherapy6
FBXL18 increases cell proliferation and reduces cell radiosensitivity in esophageal squamous cell carcinoma6
Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 study6
Digital redesign of the radiotherapy course for medical students with a blended learning approach6
Effect of radiotherapy on the DNA cargo and cellular uptake mechanisms of extracellular vesicles6
CBCT-based online adaptive radiotherapy of the prostate bed: first clinical experience and comparison to nonadaptive conventional IGRT5
Radiotherapie plus Durvalumab beim lokal fortgeschrittenen NSCLC: die DOLPHIN-Studie5
DEGRO 2024 Abstractband5
Artificial intelligence for response prediction and personalisation in radiation oncology5
Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery5
Initial needle tracking with the first standalone combined infrared camera – CT system for brachytherapy—analysis of tracking accuracy and uncertainties5
CT-based radiomics prediction of complete response after stereotactic body radiation therapy for patients with lung metastases5
Irradiation alters extracellular vesicle microRNA load in the serum of patients with leukaemia5
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost5
Comparative analysis of different modalities of radiotherapy in vestibular schwannoma: tumor control, symptom evolution, and toxicity profiles5
Low doses to the heart in daily practice for treating left-sided breast cancer using accelerated partial-breast irradiation by multicatheter brachytherapy and deep-inspiration breath-hold using a SIB5
Tenth anniversary of the Young DEGRO Team Trial—reflecting on the past, shaping the future5
Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study5
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation5
Radiochirurgie beim Nierenzellkarzinom: Daten der multizentrischen prospektiven FASTRACK II-Studie5
Dose–effect relationship between dose–volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center5
Influence of chemoradiation on the immune microenvironment of cervical cancer patients5
Präoperative Strahlentherapie und Pembrolizumab bei lokalisierten Weichteilsarkomen der Extremitäten: Ergebnisse der multizentrischen, randomisierten SU2C-SARC032-Studie5
In memory of Univ.-Prof. Dr. med. Normann Willich (1946–2024)5
Dosisreduktion der elektiven Lymphabflussbestrahlung bei Kopf-Hals-Karzinomen: bereit für die klinische Routine?5
Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice5
Dosimetric comparison of advanced radiation techniques for scalp-sparing in low-grade gliomas5
Die MIRAGE-Studie (MR-Linac-basierte Körperstereotaxie bei Prostatakarzinomen) – Precision at its best?5
Incidence of radiation necrosis following different radiotherapy fractionation schedules for intracranial meningiomas5
Integrated approaches to sensitizing melanoma to radiotherapy4
From radiation beams to digital streams: social media engagement of German radiotherapy facilities4
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce “Imaging in Stereotactic Radiotherapy”4
Dosiseskalation mittels Brachytherapie zur Erhöhung der Organerhaltungsrate beim Rektumkarzinom4
Prognostic significance of the mEPE score in intermediate-risk prostate cancer patients undergoing ultrahypofractionated robotic SBRT4
Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating4
Role of resting-state functional MRI in detecting brain functional changes following radiotherapy for head and neck cancer: a systematic review and meta-analysis4
Traditional risk factors and nodal yield—still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?4
Navigating through recent evidence on locoregional breast cancer radiotherapy: an initiative by the scientific association of Swiss radiation oncology4
Role of palliative SBRT in barcelona clinic liver cancer-stage C hepatocellular carcinoma patients4
Die Rolle der Chemotherapie im Kontext der Bestrahlung beim Nasopharynxkarzinom: Update der MAC-NPC-Netzwerk-Metaanalyse4
Mobile applications in radiation oncology—current choices and future potentials4
Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie4
Bestrahlen oder nicht bestrahlen bei älteren Patientinnen mit Low-Risk-Mammakarzinom? Erkenntnisse aus den 10-Jahres-Daten der PRIME-II-Studie4
Is model-based dose calculation based on cone-beam computed tomography suitable for adaptive treatment planning in brachytherapy?4
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer4
Proton beam therapy versus trans-arterial chemoembolization for BCLC stage B hepatocellular carcinoma—a propensity-matched analysis4
Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma4
State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment4
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients4
Vorasidenib bei niedriggradigen Gliomen – neues Therapieprinzip mit offenen Fragen zu den Langzeitergebnissen4
Effects of intrafractional motion on targeting accuracy in frameless single-isocenter multi-target stereotactic radiosurgery4
Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography4
Strukturelle, prozedurale und personelle Voraussetzung für die Erbringung radioonkologischer und strahlentherapeutischer Leistungen 2023 in Deutschland – ein Positionspapier der Deutschen Gesellschaft4
Sarcopenia in glioblastoma: the imaging we need and what it tells us4
Prognostic parameters for local control and survival after radiotherapy of stabilized bone metastases4
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review4
Radiotherapy of localized orbital mantle cell lymphoma: a SEER database analysis of long-term outcomes4
Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin4
Head and neck NUT carcinoma—radiotherapy dose, chemotherapy choice, and outcomes: lessons from a 7-year complete remission4
From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer4
Implementing stereotactic arrhythmia radioablation with STOPSTORM.eu consortium support: intermediate results of a prospective Israeli single-institutional trial4
Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses4
Re-irradiation in progressive diffuse infiltrative pontine glioma in children and young adults4
Ethical considerations of prospective data collection for stereotactic arrhythmia radioablation (STAR): an overview from the STOPSTORM.eu consortium4
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study4
Proton therapy reduces the effective dose to immune cells in breast cancer patients4
Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention4
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?4
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospe4
The effect of incidental dose to pelvic nodes in bladder-only irradiation in the era of IMRT: a dosimetric study4
Carbon ion radiotherapy optimization techniques for pancreatic cancer: accounting for the effect of bowel gas variation4
Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma4
Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma4
Analysis of radiation oncology integration within general practitioners’ daily patient care: a cross-sectional survey in Germany4
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community3
Verbesserte Schluckfunktion nach definitiver Radiochemotherapie bei Oro- und Hypopharynxkarzinomen durch Schonung der Musculi constrictores pharyngis3
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report3
Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany—results from a national survey3
Endokavitäre Kontakttherapie vs. EBRT als Boost bei organerhaltender Strahlentherapie von T2–3-Rektumkarzinomen: Ergebnisse der OPERA-Studie3
Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning3
Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures3
Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany—the SUFEETUBE project3
DEGRO 2026 Abstractband3
Abwarten oder Radiochirurgie bei asymptomatischen Vestibularisschwannomen3
Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT3
Biomarkers in prostate cancer: current status and future directions in radiotherapy—statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)3
Hypofractionated and conventionally fractionated radiotherapy for synchronous bilateral breast cancer: clinical and dosimetric outcomes3
Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas3
Definitive (chemo)radiotherapy of enteric-type adenocarcinoma of the lung: time to unmask an underrated treatment option?3
Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy3
Protonen- versus Photonenbestrahlung beim Oropharynxkarzinom3
Clinical outcome in metastatic prostate cancer after primary radiotherapy3
Letter to the Editor: reply to “Comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy”3
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™—a substitute for gold fiducial-based IGRT?3
Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 20233
Erst-Generations-TKI und simultane thorakale Radiotherapie bei EGFR-mutiertem, metastasiertem Non-Small Cell Lung Cancer (NSCLC): ein vielversprechender neuer Ansatz?3
The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma3
5-Jahres-Follow-up der RAPIDO-Studie: Zurück in die Zukunft der Langzeitradiochemotherapie bei totaler neoadjuvanter Therapie (TNT) des lokal fortgeschrittenen Rektumkarzinoms?3
Potential prognostic role of the 18F-FDG PET/CT metabolic response in locally advanced cervical cancer after definitive chemoradiotherapy: a narrative review3
Contouring in transition: perceptions of AI-based autocontouring by radiation oncologists and medical physicists in German-speaking countries3
Stereotaktische Bestrahlung statt Ganzhirnradiatio bei 1–10 Hirnmetastasen auch bei kleinzelligem Lungenkarzinom?3
Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy3
Bakterielle Dekolonisierung mit Mupirocin-Nasensalbe reduziert schwere orale Radiomukositis bei Nasopharynxkarzinom – Ergebnisse einer randomisierten Phase-III-Studie3
Dual therapy with nanohydroxyapatite and vitamin E restores irradiated dentin via remineralization and collagen protection3
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation3
Association of long-term treatment outcomes with changes in PET/MRI characteristics and the type of early treatment response during concurrent radiochemotherapy in patients with locally advanced cervi3
Investigating the impact of breast positioning control on physical treatment parameters in multi-catheter breast brachytherapy3
Risk management patterns in radiation oncology—results of a national survey within the framework of the Patient Safety in German Radiation Oncology (PaSaGeRO) project3
Weniger ist mehr: Deeskalation der Dosis beim frühen Analkarzinom – klinische und funktionelle Aspekte zur Lebensqualität aus der PLATO-ACT4-Studie3
Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China3
Hyaluronsäurespacer zur Optimierung der Rektumdosis bei hypofraktionierter Radiotherapie der Prostata3
Robustness analysis of surface-guided DIBH left breast radiotherapy: personalized dosimetric effect of real intrafractional motion within the beam gating thresholds3
Successful hemostatic radiotherapy for massive airway bleeding from infectious pulmonary cavity: a case report3
Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity3
Prophylaktische Strahlentherapie bei asymptomatischen Hochrisiko-Knochenmetastasen3
Correction: Verbesserung der Ernährungssituation von Patienten mit fortgeschrittenem nicht-kleinzelligem Lungenkarzinom (NSCLC) durch Off-label-Medikation2
Gender role in radiotherapy: psychosocial differences between males and females during cancer care2
The estimated dose of radiation to immune cells predicts lymphopenia and reveals technique-Dependent immune sparing in postoperative radiotherapy for early esophageal cancer2
Präoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie2
Development, implementation, and results of a simulation-based hands-on brachytherapy workshop for medical students2
Radiotherapy and DNA damage response inhibitors modestly sensitize HNSCC to NK cell killing, with ATM inhibition more effective than ATR inhibition2
Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002)2
Hypofraktionierte Split-course-Radiotherapie bei älteren gebrechlichen Patienten mit Kopf-Hals-Plattenepithelkarzinomen2
Low-dose CBCT image reconstruction: a review2
The role of radiotherapy in intracranial hemangiopericytoma/solitary fibrous tumors2
Timing matters: how mechanism-guided sequencing shapes the efficacy of radiotherapy-immunotherapy combinations2
Prognose und lokale Behandlungsmethoden des Merkel-Zell-Karzinoms2
Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust2
0.26840114593506